Symbol
| CTNNA3
| contributors: mct - updated : 15-10-2010
|
HGNC name
| catenin (cadherin-associated protein), alpha 3
|
HGNC id
| 2511
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
with monoallelic and biallelic expression patterns in tumor bladder tissue | constitutional
|  
|  
|  
|  
|
silencing of STOX1 or CTNNA3 leads to a change in extravillous trophoblast phenotype toward a non-proliferative cell type in the early placenta | |
Susceptibility
|
to late-onset Alzheimer disease(LOAD)in females to toluene diisocyanate-induced asthma (TDI) |
Variant & Polymorphism
SNP
| SNP 4360 and 4783 significatively associated with LOAD in females (SNP exhibited no interaction with the APOE-epsilon4 allele) |
|
polymorphism in the 3' downstream region of CTNNA3 (rs1786929), significantly associated with the TDI-induced asthma phenotype |
|
|
Candidate gene
Marker
Therapy target
| | | |